Alticef-TZ 250mg/31.25mg Injection
Marketer
Ultra Drugs Pvt Ltd
Salt Composition
Ceftriaxone (250mg) + Tazobactum (31.25mg)
Overview Alticef-TZ 250mg/31.25mg Injection
Ceftazidime/Tazobactam 250mg/31.25mg injection is a dual-action antibiotic used to combat diverse bacterial infections. Its mechanism involves inhibiting bacterial growth and preventing infection spread. Administration must be overseen by a qualified medical practitioner; adherence to the prescribed dosage schedule is crucial. Complete the entire course of treatment, regardless of symptom improvement, as premature cessation might compromise efficacy. Typical side effects include nausea, vomiting, diarrhea, and dyspepsia; intensified side effects necessitate immediate medical consultation. Seek urgent medical attention for any allergic response (skin rashes, itching, swelling, respiratory distress). Inform your physician about all current medications before commencing treatment. Pregnant or lactating individuals should consult their doctor prior to use. Alcohol consumption should be avoided due to potential increased drowsiness. While driving ability isn't usually affected, refrain from driving if drowsiness or dizziness occur. Adequate rest, nutritious food, and sufficient hydration promote recovery. Your doctor may order lab tests to monitor treatment response.
Primary Ingredients of Alticef-TZ 250mg/31.25mg Injection
No information provided. Please provide the text you wish me to rephrase.
Uses of Alticef-TZ 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Alticef-TZ 250mg/31.25mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Alticef-TZ 250mg/31.25mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Alticef-TZ 250mg/31.25mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Alticef-TZ 250mg/31.25mg Injection works:
Ceftriaxone and Tazobactum, combined as Alticef-TZ 250mg/31.25mg Injection, offer a targeted antibacterial approach. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering their growth and survival. Tazobactum's role as a beta-lactamase inhibitor counters bacterial resistance mechanisms, thus bolstering Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Alticef-TZ 250mg/31.25mg Injection use alongside alcohol consumption presents no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Alticef-TZ 250mg/31.25mg is typically deemed safe for pregnant individuals. Preclinical trials using animals have revealed minimal or no negative consequences for fetal development; nevertheless, research involving human subjects is scarce.
Breast feedingCAUTION
The administration of Alticef-TZ 250mg/31.25mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's course of treatment and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Alticef-TZ 250mg/31.25mg Injection may induce drowsiness, visual disturbances, and dizziness. Operation of a motor vehicle is contraindicated while experiencing these effects.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Alticef-TZ 250mg/31.25mg Injection to individuals with renal impairment. Seek medical advice from your physician.
LiverCAUTION
Caution is advised when administering Alticef-TZ 250mg/31.25mg Injection to individuals with significant hepatic impairment; dosage modification may be necessary. A physician's consultation is recommended. Altering the dosage of Alticef-TZ 250mg/31.25mg Injection is not suggested for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Alticef-TZ 250mg/31.25mg Injection :
Should you inadvertently skip a dose of Alticef-TZ 250mg/31.25mg Injection, seek immediate medical advice.
Facts to Know About Alticef-TZ 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Treatment | Antimicrobial Agents |
3,018 People bought this recently